Abstract

BackgroundOpioids are currently prescribed for chronic non-cancer pain (CNCP), and some patients use opioids continuously for long-term treatment. Stakeholders’ awareness about long-term opioid therapy is essential for improving the safety and effectiveness of pain treatment. The purpose of this study is to explore the perspectives of pain specialists, patients, and family caregivers about long-term opioid use in CNCP management.MethodsThis study was a qualitative study and adhered to the COREQ guidelines. Pain specialists (n = 12), patients (n = 14), and family members (n = 9) were recruited to the study by purposive sampling at the Pain Clinic of Ramathibodi Hospital. Semi-structured interviews were recorded, verbatim transcribed, conceptually coded, and analyzed using Atlas.ti 8.0.ResultsAll groups of participants described opioids as non-first-line drugs for pain management. Opioids should be prescribed only for severe pain, when non-opioid pharmacotherapy and non-pharmacological therapies are not effective. Patients reported that the benefits of opioids were for pain relief, while physicians and most family members highlighted that opioid use should improve functional outcomes. Physicians and family members expressed concerns about opioid-related side effects, harm, and adverse events, while patients did not. Patients confirmed that they would continue using opioids for pain management under supervision. However, physicians stated that they would taper off or discontinue opioid therapy if patients’ pain relief or functional improvement was not achieved. Both patients and family members were willing to consider non-pharmacological therapies if potential benefits existed. Patient education, doctor–patient/family relationships, and opioid prescription policies were proposed to enhance CNCP management.ConclusionLong-term opioid therapy for CNCP may be beneficial in patients who have established realistic treatment goals (for both pain relief and functional improvement) with their physicians. Regular monitoring and evaluation of the risks and benefits, adverse events, and drug-related aberrant behaviors are necessary. Integrated multimodal multidisciplinary therapies and family member collaborations are also important for improving CNCP management.

Highlights

  • Opioids are currently prescribed for chronic non-cancer pain (CNCP), and some patients use opioids continuously for long-term treatment

  • Study design and setting A qualitative, cross-sectional study was conducted in the form of semi-structured interviews with pain specialists, CNCP patients, and their family members at the Pain Clinic of Ramathibodi Hospital in Bangkok, Thailand and adhered to the COREQ guidelines

  • Attitudes about prescribing opioids Pain specialists reported that some patients have complex and severe chronic pain that is not responsive to non-opioids, pain intervention, physical therapy, or other alternative treatments

Read more

Summary

Introduction

Opioids are currently prescribed for chronic non-cancer pain (CNCP), and some patients use opioids continuously for long-term treatment. A 2013 study reported that Thailand had a high prevalence of CNCP: almost 20% of the working population [4]. The aims of treatment in these patients focus on reducing pain scores and improving function and quality of life. Previous studies have reported that short-term opioid therapy is moderately effective for pain relief and small improvements in functional outcomes [7,8,9,10,11,12]. Recent evidence has shown an increase in the incidence and prevalence of long-term opioid therapy for CNCP, but studies of its efficacy and outcomes remain inconclusive [13, 14]

Objectives
Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call